---
$id: https://graph.org.ai/products/commodity/51162747
$type: Product
source: UNSPSC
code: "51162747"
title: "Xylometazoline"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Xylometazoline

**UNSPSC Code**: 51162747
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) WPY40FTH8K, chemically known as 2-imidazoline, 2-(4-tert-butyl-2,6-dimethylbenzyl)- but more generally known as xylometazoline, which bears US NIH Compound Identifier 5709. European Medicines Agency schedules Xylometazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00122MIG. The term XYLOMETAZOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules xylometazoline in its Anatomical Therapeutic Chemical (ATC) Classification. XYLOMETAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule xylometazoline under HS 29332990 and SITC 51573. As of Q4 2014, XYLOMETAZOLINE remains US FDA's Preferred Term for this commodity. Xylometazoline bears US NLM identifiers UMLS ID C0078643 and NCI Concept Code C87749. SMILES: N1C(=NCC1)CC1C(CC(C(C)(C)C)CC1C)C.

